246 related articles for article (PubMed ID: 12089226)
1. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
Pagliaro LC; Millikan RE; Tu SM; Williams D; Daliani D; Papandreou CN; Logothetis CJ
J Clin Oncol; 2002 Jul; 20(13):2965-70. PubMed ID: 12089226
[TBL] [Abstract][Full Text] [Related]
2. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.
Bellmunt J; Guillem V; Paz-Ares L; González-Larriba JL; Carles J; Batiste-Alentorn E; Sáenz A; López-Brea M; Font A; Nogué M; Bastús R; Climent MA; de la Cruz JJ; Albanell J; Banús JM; Gallardo E; Diaz-Rubio E; Cortés-Funes H; Baselga J
J Clin Oncol; 2000 Sep; 18(18):3247-55. PubMed ID: 10986057
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.
Lin CC; Hsu CH; Huang CY; Keng HY; Tsai YC; Huang KH; Cheng AL; Pu YS
Anticancer Drugs; 2007 Apr; 18(4):487-91. PubMed ID: 17351402
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
Bajorin DF; McCaffrey JA; Dodd PM; Hilton S; Mazumdar M; Kelly WK; Herr H; Scher HI; Icasiano E; Higgins G
Cancer; 2000 Apr; 88(7):1671-8. PubMed ID: 10738226
[TBL] [Abstract][Full Text] [Related]
6. A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.
Winquist E; Wilson JJ; Dorreen M; Wong R; Jonker D; Iscoe N
Can J Urol; 2004 Dec; 11(6):2445-9. PubMed ID: 15636670
[TBL] [Abstract][Full Text] [Related]
7. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
8. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
9. Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
Milowsky MI; Nanus DM; Maluf FC; Mironov S; Shi W; Iasonos A; Riches J; Regazzi A; Bajorin DF
J Clin Oncol; 2009 Sep; 27(25):4062-7. PubMed ID: 19636012
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.
Bajorin DF; McCaffrey JA; Hilton S; Mazumdar M; Kelly WK; Scher HI; Spicer J; Herr H; Higgins G
J Clin Oncol; 1998 Aug; 16(8):2722-7. PubMed ID: 9704723
[TBL] [Abstract][Full Text] [Related]
11. Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
Bajorin DF
Eur J Cancer; 2000 Jul; 36 Suppl 2():26-9. PubMed ID: 10908845
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.
Ardavanis A; Tryfonopoulos D; Alexopoulos A; Kandylis C; Lainakis G; Rigatos G
Br J Cancer; 2005 Feb; 92(4):645-50. PubMed ID: 15685232
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma.
Tsukamoto T; Yonese J; Ohkubo Y; Fukui I
Cancer; 2006 Jun; 106(11):2363-8. PubMed ID: 16649219
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.
Philips GK; Halabi S; Sanford BL; Bajorin D; Small EJ;
BJU Int; 2008 Jan; 101(1):20-5. PubMed ID: 17922873
[TBL] [Abstract][Full Text] [Related]
15. Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase II clinical trial.
von der Maase H; Andersen L; Crinò L; Weinknecht S; Dogliotti L
Ann Oncol; 1999 Dec; 10(12):1461-5. PubMed ID: 10643537
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trial.
Lorusso V; Manzione L; De Vita F; Antimi M; Selvaggi FP; De Lena M
J Urol; 2000 Jul; 164(1):53-6. PubMed ID: 10840423
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features.
Shannon C; Crombie C; Brooks A; Lau H; Drummond M; Gurney H
Ann Oncol; 2001 Jul; 12(7):947-52. PubMed ID: 11521800
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.
Pectasides D; Aravantinos G; Kalofonos H; Kiamouris C; Bafaloukos D; Xiros N; Nicolaides C; Visvikis A; Dimopoulos MA
Ann Oncol; 2001 Oct; 12(10):1417-22. PubMed ID: 11762814
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
Kaufman D; Raghavan D; Carducci M; Levine EG; Murphy B; Aisner J; Kuzel T; Nicol S; Oh W; Stadler W
J Clin Oncol; 2000 May; 18(9):1921-7. PubMed ID: 10784633
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma.
Urakami S; Fujii Y; Yamamoto S; Yuasa T; Kitsukawa S; Sakura M; Yano A; Saito K; Masuda H; Yonese J; Fukui I
Urol Oncol; 2014 Jan; 32(1):35.e1-7. PubMed ID: 23562233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
